Molecular Templates Inc recorded a cumulative net loss of $-48 million during 12 month ending in the second quarter 2024.
The Healthcare sector has seen employees of 212 other companies achieving higher income per employee. While Molecular Templates Inc 's total ranking has deteriorated compared to the previous quarter from 2222 to 3846.

What is Income per Employee Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Net Income per Employee▼

None ▼

Net Income per Employee▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

MTEM Net Income per Employee	(Jun 30 2024) II. Quarter	(Mar 31 2024) I. Quarter	(Dec 31 2023) IV. Quarter	(Sep 30 2023) III. Quarter	(Jun 30 2023) II. Quarter
Y / Y Net Income Change	-	-94.73 %	-	-83.14 %	-
Net Income per Employee (TTM) $	-781,597	-826,290	-660,597	422,242	752,645
MTEM's Total Ranking	# 3846	# 2222	# 528	# 102	# 0
Seq. Net Income Change	-	-	-	-	-

MTEM Company Profile >> Back to MTEM Efficiency Comparisons >> Compare MTEM Net Income per Employee to its Competitors

MTEM Net Income per Employee Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 213
Healthcare Sector	# 599
Overall Market	# 3846

Net Income per Employee Statistics
High	Average	Low
$ 1,768,968	$ 563,087	$ -781,597
(Mar 31 2021)		(Jun 30 2024)

News about Molecular Templates Inc Income per employee

Molecular Templates Announces $9.5 Million Private Placement Offering and Agreement to Amend Second Tranche of July 2023 Purchase Agreement, Paving the Way for Accelerated Research and Development Efforts in Novel Cancer Therapies.

Molecular Templates, a leading biopharmaceutical company based in Austin, Texas, has recently announced a definitive amended and restated securities purchase agreement with several healthcare investors. This agreement is set to provide a substantial $9.5 million in gross proceeds to Molecular Templates through the closing of the second tranche of its previously announced July 2023 private placement and purchase agreement. The financing round is being led by BVF Partners L.P., along with the participation of existing investors such as BB Biotech AG and Sant, as well as other prominent institutional investors.
Molecular Templates specializes in the discovery and development of proprietary targeted biologic therapeutics, known as engineered toxin bodies. These therapeutics hold great promise in creating novel therapies that possess potent and differentiated mechanisms of action for the treatment of cancer. The company s cutting-edge research and development efforts have gained recognition in the biopharmaceutical industry.

Companies with similar Income per Employee for 12 month ending Jun 30 2024, within Healthcare Sector

Income per Employee

Income 12 month ending Jun 30 2024

Number of Employees Jun 30 2024

Date modified: 2026-08-29T17:15:56+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.